SCHEMBL31248369

SCHEMBL31248369

COC(=O)C(COC(=O)c1ccccc1)NC(=O)c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.54
▸ GAA P10253 3/20 0.52
▸ RAB9A P51151 2/20 0.52
▸ ADRB2 P07550 2/20 0.51
▸ ADRB1 P08588 2/20 0.51
▸ ADRB3 P13945 2/20 0.51
▸ LMNA P02545 2/20 0.51
▸ GLA P06280 1/20 0.51
▸ CTSL P07711 3/20 0.50
▸ KMT2A Q03164 1/20 0.50
▸ TSHR P16473 2/20 0.49
▸ CYP26A1 O43174 1/20 0.48
▸ L3MBTL1 Q9Y468 1/20 0.48
▸ SMN1; SMN2 Q16637 2/20 0.48
▸ NPC1 O15118 1/20 0.48
▸ CTSB P07858 1/20 0.47
▸ CTSS P25774 1/20 0.47
▸ CTSK P43235 1/20 0.47
▸ TAS1R3 Q7RTX0 1/20 0.46
▸ TAS1R1 Q7RTX1 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10802099 0.88 ALDH1A1 (0.57) ALDH1A1GAARAB9AADRB2ADRB1
SCHEMBL21950433 0.85 ADRB2 (0.52) ALDH1A1ADRB2ADRB1ADRB3KMT2A
SCHEMBL14535743 0.84 GAA (0.54) ALDH1A1GAARAB9ALMNAGLA
SCHEMBL18127213 0.84 GAA (0.61) ALDH1A1GAARAB9ALMNAGLA
SCHEMBL24130633 0.83 GAA (0.53) ALDH1A1GAARAB9ALMNAGLA
SCHEMBL24130632 0.83 GAA (0.53) ALDH1A1GAARAB9ALMNAGLA
SCHEMBL13192035 0.83 ADRB2 (0.59) ALDH1A1GAARAB9AADRB2ADRB1
SCHEMBL10024019 0.83 GAA (0.56) ALDH1A1GAARAB9ALMNAGLA
SCHEMBL3679721 0.83 RAB9A (0.59) ALDH1A1GAARAB9ALMNAGLA
SCHEMBL5672076 0.83 GAA (0.56) ALDH1A1GAARAB9ALMNAGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4698170-A1 GLYCINAMIDE DERIVATIVES FOR USE IN THE TREATMENT OF SALMONELLOSIS Eberhard-Karls-Universität Tübingen (DE) 2026-02-25 — — EP disclosed
WO-2024218333-A1 GLYCINAMIDE DERIVATIVES FOR USE IN THE TREATMENT OF SALMONELLOSIS EBERHARD KARLS UNIVERSITÄT TÜBINGEN MEDIZINISCHE FAKULTÄT (DE) 2024-10-24 — — WO disclosed
Send feedback